The FASEB Journal · 2004 · 222 citations · 26 references
Life SciencesBiochemistryMolecular BiologyCarcinogenesisCell SignalingSignal TransductionAdhesion MoleculesExtracellular MatrixLigand BindingProtein-ligand BindingProtein-ligand InteractionsReceptor-ligand InteractionsDentin Matrix MetalloproteinasesIntegrin BindingIntegrin-binding LigandsIntegrin-ligand BindingIntrinsic FluorescenceMatrix MetalloproteinasesProtein Structural ChangesSerum Protein Binding
Matrix metalloproteinases (MMPs) are critical for development, wound healing, and for the progression of cancer. It is generally accepted that MMPs are secreted in a latent form (proMMP) and are activated only upon removal of their inhibitory propeptides. This report shows that three members of the SIBLING (Small, Integrin-Binding LIgand, N-linked Glycoprotein) family can specifically bind (Kd approximately equal nM) and activate three different MMPs. Binding of SIBLING to their corresponding proMMPs is associated with structural changes as indicated by quenching of intrinsic tryptophan fluorescence, increased susceptibility to plasmin cleavage, and decreased inhibition by specific natural and synthetic inhibitors. Activation includes both making the proMMPs enzymatically active and the reactivation of the TIMP (tissue inhibitors of MMP) inhibited MMPs. Bone sialoprotein specifically binds proMMP-2 and active MMP-2, while osteopontin binds proMMP-3 and active MMP-3, and dentin matrix protein-1 binds proMMP-9 and active MMP-9. Both pro and active MMP-SIBLING complexes are disrupted by the abundant serum protein, complement Factor H, thereby probably limiting SIBLING-mediated activation to regions immediately adjacent to sites of secretion in vivo. These data suggest that the SIBLING family offers an alternative method of controlling the activity of at least three MMPs.
26
Matrix metalloproteinase-9 triggers the angiogenic switch during carcinogenesis
Gabriele Bergers, Rolf A. Brekken, Gerald McMahon et al. · Nature Cell Biology · 2000 · 2.8K citations · Full text
Medicine, Cancer Biology, Oncology +14
Elevated serum bone sialoprotein and osteopontin in colon, breast, prostate, and lung cancer.
Neal S. Fedarko, Alka Jain, Abdullah Karadağ et al. · PubMed · 2001 · 382 citations